The two pharmaceutical giants — which own household brands like Advil and Tums — said in a statement Wednesday that the new company would have combined sales of $12.7 billion a year.
Britain's GSK (GSK) will control just over two-thirds of the joint venture, with US-based Pfizer (PFE) holding the rest.
This is a developing story.
Bagikan Berita Ini
0 Response to "Advil meet Panadol: Pfizer and GSK are merging their consumer healthcare businesses"
Post a Comment